AveXis | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (35)

View All

Latest Posts

About This Stock More About This Stock
Biotechs Soar After Big Trump Drug Price Speech- Mid-Caps Should Outperform
Article By: Rod Raynovich
Monday, May 14, 2018 2:11 PM EDT
Biotechs soared Friday immediately after Trump’s much-anticipated new drug plan speech which was going to address high drug prices and potentially bring more government intervention.
In this article: ARRY, IBB, FBT, XBI, LGND, CLVS, AGIO, BLUE, LOXO, NVCR, AVXS, NVS
Read
Biotech And Pharma Stocks Await Q1 Earnings But Gene Editing Stocks Sell-Off
Article By: Rod Raynovich
Monday, April 23, 2018 5:38 PM EDT
Biotech stocks held current levels but small caps and speculative stocks sold off with the XBI down 1%.
In this article: MRK, AMGN, NBIX, XBI, GWPH, BLUE, CLLS, PTLA, EDIT, AVXS, NTLA, CRSP
Read
Novartis Beats Earnings And Revenue Estimates In Q1
Article By: Zacks Investment Research
Thursday, April 19, 2018 12:14 PM EDT
Novartis AG reported encouraging results for first-quarter 2018 wherein both earnings and revenues beat estimates driven by strong performance of Cosentyx and Entresto.
In this article: NVS Also: GSK, ONCE, AVXS
Read
Morning Call For Tuesday, February 13
Article By: Jim Van Meerten
Tuesday, February 13, 2018 7:46 AM EDT
Mar E-mini S&Ps (ESH18 -0.45%) this morning are down -0.51% after two days of gains.
In this article: MOH, AVXS, CBOE, NTAP, RETA, VECO, AMKR
Read
Biotech Digest – CLRB Reports Positive Results, TNDM Receives New Patent, DERM Inks New Deal
Article By: KKD Healthcare Analytics
Wednesday, August 9, 2017 10:13 AM EDT
Cellectar Biosciences stock shot up as the company announced achieving overall survival of 22.5 months to date after a single dose infusion of 12.5mCi/m2 in patients with multiple myeloma.
In this article: AET, AGN, BDX, JNJ, SNY, PLX, ACRX, ANTH, TNDM, AMRN, DERM, AKBA, AVXS, CLRB, ZBH
Read
All Posts

Latest Tweets for $AVXS

No tweets yet!

PARTNER HEADLINES